AI assistant
Sending…
Entera Bio Ltd. — Director's Dealing 2022
Jan 11, 2022
35604_dirs_2022-01-11_da41423b-27ba-4282-88a9-1e35bc15f81a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2022-01-01
Reporting Person: GARCEAU ROGER (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share | 4940 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $3.69 | 2027-11-10 | Ordinary Shares, par value NIS 0.0000769 per share (147290) | Direct | |
| Stock Option (right to buy) | $6.08 | 2023-04-06 | Ordinary Shares, par value NIS 0.0000769 per share (209040) | Direct |
Footnotes
F1: The options vested on a monthly basis over a three-year period that commenced January 1, 2017.
More from Entera Bio Ltd.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 9